Blog Archives - Lexadept IP Associates

Pharma Trademarks

No Trademark infringement, if the trademark is derived from the INN Name of API

November 26, 2022IP litigation, letroz letero, pharma trademark litigation, Sun pharma hetero, trademark case, Trademark infringement, Trademark infringement india, trademark litigation indiaBlogph13030083162_kj63e10j

No trademark infringement when the trademark is derived from the INN of API – Delhi HC

Grace Period and anticipation exemptions

Grace Period after Disclosures & Anticipation Exceptions – Provisions in Indian Patents Act

November 18, 2022anticipation indian patent act, Grace period India patent, Grace period Indian patent act, section 29 Indian patent act, section 30 Indian patent act, section 31 indian patent act, section 32 indian patent act, section 33 indian patent act, section 34 indian patent actBlogph13030083162_kj63e10j

Grace period and anticipation exceptions under various provisions in the Indian Patent Act allowed after disclosure

Unknown compound

Delhi HC holds that IPO must identify”Known Substance” for raising objections under Sec 3(d)

November 17, 2022IPO section 3d, IPO section 3d objection, patent 3d objection, Patent 3d rejection, Patent objections 3D, replying 3d rejection, section 3d Indian patent actBlogph13030083162_kj63e10j

Patent Office should identify Known Substance for raising Sec 3(d) objections – Delhi High Court